SCHEMBL10823534

SCHEMBL10823534

Cc1cc(S(=O)(=O)Nc2cccc3c(O)ccc(S(=O)(=O)O)c23)ccc1NC(=O)Nc1ccc(S(=O)(=O)Nc2cccc3c(O)ccc(S(=O)(=O)O)c23)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ EP300 Q09472 1/20 0.45
▸ KAT2B Q92831 1/20 0.45
▸ KAT8 Q9H7Z6 1/20 0.45
▸ MEN1 O00255 6/20 0.44
▸ KMT2A Q03164 6/20 0.44
▸ MAP1LC3B Q9GZQ8 1/20 0.44
▸ HPSE Q9Y251 2/20 0.43
▸ PSD A5PKW4 1/20 0.42
▸ GAA P10253 3/20 0.42
▸ G6PD P11413 1/20 0.42
▸ POLB P06746 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ PKM P14618 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10823417 0.97 EP300 (0.46) CA12CA1CA2CA9EP300
SCHEMBL10823477 0.92 CA12 (0.45) CA12CA1CA2CA9EP300
SCHEMBL10823487 0.89 EP300 (0.46) CA12CA1CA2CA9EP300
SCHEMBL10823471 0.89 EP300 (0.44) CA12CA1CA2CA9EP300
SCHEMBL10823448 0.88 HPSE (0.44) CA12CA1CA2CA9EP300
SCHEMBL10823535 0.84 EP300 (0.43) CA12CA1CA2CA9EP300
SCHEMBL10823370 0.84 EP300 (0.43) CA12CA1CA2CA9EP300
SCHEMBL10823552 0.84 MEN1 (0.51) CA12CA1CA2CA9MEN1
SCHEMBL10823362 0.84 MEN1 (0.46) EP300KAT2BKAT8MEN1KMT2A
SCHEMBL10823401 0.83 CA12 (0.42) CA12CA1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H83-H Dental antiplaque agents and inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1986-07-01 — — US disclosed
Send feedback